Cytokine mediation of ozone-induced pulmonary adaptation

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 5, 1998, Pages 696-705

  McKinney, Willie J ^b   Jaskot, Richard H ^b   Richards, Judy H ^b   Costa, Daniel L ^b   Dreher, Kevin L ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

ANTIBODY; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; OZONE;

ADAPTATION; AIR POLLUTION; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CIRCADIAN RHYTHM; DRUG EFFECT; IMMUNOLOGY; LUNG; LUNG LAVAGE; MALE; METABOLISM; PHOTOCHEMICAL SMOG; PNEUMONIA; RAT; WISTAR RAT;

ADAPTATION, PHYSIOLOGICAL; AIR POLLUTION; ANIMALS; ANTIBODIES; BRONCHOALVEOLAR LAVAGE FLUID; CIRCADIAN RHYTHM; CYTOKINES; INTERLEUKIN-6; LUNG; MALE; OXIDANTS, PHOTOCHEMICAL; OZONE; PNEUMONIA; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-6;

EID: 0032063309     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.5.2928     Document Type: Article

References (56)

1. Kehrl, H. R., L. M. Vincent, R. J. Kowalsky, D. H. Horstman, J. J. O'Neil, W. H. McCartney, and P. A. Bromberg. 1987. Ozone exposure increases respiratory epithelial permeability in humans. Am. Rev. Respir. Dis. 135: 1124-1128.
2. Bhalla, D. K., R. C. Mannix, S. M. Lavan, R. F. Phalen, M. T. Kleinman, and T. T. Crocker. 1987. Tracheal and bronchoalveolar permeability changes in rats inhaling oxidant atmospheres during rest or exercise. J. Toxicol. Environ. Health 22:417-437.
3. Seltzer, J., B. G. Bigby, M. Stulborg, M. J. Holtzman, J. A. Nadel, I. F. Ueki, G. D. Leikauf, E. J. Goetzl, and H. A. Boushey. 1986. Ozone-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J. Appl. Physiol. 60:1321-1326.
4. Koren, H. S., R. B. Devlin, D. E. Graham, R. Mann, M. P. McGee, D. H. Horstman, W. J. Kozumbo, S. Becker, D. E. House, W. F. McDonnell, and P. A. Bromberg. 1989. Ozone-induced inflammation in the lower airways of human subjects. Am. Rev. Respir. Dis. 139:407-415.
5. Van Bree, L., P. J. A. Rombout, I. M. C. M. Rietjens, J. A. M. A. Dormans, and M. Marra. 1989. Pathobiochemical effects in rat lung related to episodic ozone exposure. In Atmospheric Ozone Research and its Policy Implications. T. Schneider, editor. Elsevier Science Publishers, Amsterdam. 723-732.
6. Devlin, R. B., W. F. McDonnell, R. Perez, S. Becker, D. E. House, and H. S. Koren. 1991. Prolonged exposure of humans to ambient levels of ozone causes cellular and biochemical changes in the lung. Am. Rev. Respir. Dis. 4:72-81.
7. Wiester, M. J., J. S. Tepper, D. L. Doerfler, and D. L. Costa. 1994. Ozone adaptation in rats after chronic exposure to a simulated urban profile of ozone. Fundam. Appl. Toxicol. 24:42-51.
8. Tepper, J. S., D. L. Costa, J. R. Lehmann, M. F. Weber, and G. E. Hatch. 1989. Unattenuated structural and biochemical alterations in the rat lung during functional adaptation to ozone. Am. Rev. Respir. Dis. 140:493-501.
9. Rahman, I. U., L. B. Clerch, and D. Massaro. 1991. Rat lung antioxidant enzyme induction by ozone. Am. J. Physiol. (Lung Cell Mol. Physiol. 4) 260:L412-L418.
10. Van Bree, L., M. Marra, and P. J. A. Rombout. 1992. Differences in pulmonary biochemical and inflammatory responses of rats and guinea pigs resulting from daytime or nighttime, single and repeated exposure to ozone. Toxicol. Appl. Pharmacol. 116:209-216.
11. Wiester, M. J., W. P. Watkinson, D. L. Costa, K. M. Crissman, J. H. Richards, D. W. Winsett, and J. W. Highfill. 1996. Ozone toxicity in the rat: III. Effect of changes in ambient temperature on pulmonary parameters. J. Appl. Physiol. 81:1691-1700.
12. Alpert, S. M., and T. R. Lewis. 1971. Ozone tolerance studies utilizing unilateral lung exposure. J. Appl. Physiol. 31:243-246.
13. Nambu, Z., and E. Yokoyama. 1983. Antioxidant system and ozone tolerance. Environ. Res. 32:111-117.
14. Stokinger, H. E., W. D. Wagner, and P. G. Wright. 1956. Studies on ozone toxicity: I. Potentiating effects of exercise and tolerance development. Arch. Ind. Health 14:158-162.
15. Fairchild, E. J., II. 1967. Tolerance mechanisms. Arch. Environ. Health 14: 111-126.
16. Tsan, M. F., T. A. White, S. Y. Lee, and C. Y. Lee. 1991. Interleukin-1 protects rats against oxygen toxicity. J. Appl. Physiol. (Lung Cell Mol. Physiol. 2) 71:688-697.
17. Devlin, R. B., W. F. McDonnell, S. Becker, M. C. Madden, M. P. McGee, R. Perez, G. Hatch, D. E. House, and H. S. Koren. 1996. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for two hours: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hours after exposure. Toxicol. Appl. Pharmacol. 138:176-185.
18. Costa, D. L., J. S. Tepper, R. Devlin, M. Madden, G. E. Hatch, H. Koren, J. Boere, and P. Rombout. 1992. Differential sensitivity to acute ozone: a study of lung dysfunction and inflammation in three rat strains. The Toxicologist 12:173. (Abstr.)
19. Van Bree, L., J. Wijnands, J. Dorman, R. Vandebriel, and H. Van Loveren. 1996. Differences in cytokine gene expression in a rat model of lung inflammation following acute and repeated exposure to ozone. Am. J. Respir. Crit. Care Med. 153:A699. (Abstr.)
20. Arsalane, K., P. Gosset, D. Vanhee, C. Voisin, Q. Hamid, A. Tonnel, and B. Wallaert. 1995. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am. J. Respir. Cell Mol. Biol. 13:60-68.
21. Devlin, R., K. McKinnon, T. Noah, S. Becker, and H. Koren. 1994. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am. J. Physiol. (Lung Cell Mol. Physiol. 10) 266: L612-L619.
22. Denis, M. 1992. Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J. Leukoc. Biol. 52:197-201.
23. 2 tolerance. Am. J. Physiol. (Lung Cell Mol. Physiol. 7) 263: L22-L26.
24. Einarsson, O., B. F. DiCosmo, R. Flavell, and J. A. Elias. 1995. CC-10-IL-6 transgenic mice manifest enhanced tolerance to 100% oxygen. Am. Rev. Respir. Dis. 151:A326. (Abstr.)
25. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
26. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1243-1250.
27. DiCosmo, B. F., G. P. Geba, D. Picarella, J. A. Elias, J. A. Rankin, B. R. Stripp, J. A. Whitsett, and R. A. Flavel. 1994. Airway epithelial cell expression of interleukin-6 in transgenic mice: uncoupling of airway inflammation and bronchial hyperreactivity. J. Clin. Invest. 94:2028-2035.
28. Coulie, P. G., A. Vink, and J. Van-Snick. 1990. A monoclonal antibody specific for the murine IL-6 receptor inhibits the growth of a mouse plasmacytoma in vivo. Curr. Top. Microbiol. Immunol. 166:43-46.
29. Vink, A., P. Coulie, G. Warnier, J. C. Renauld, M. Stevens, D. Donckers, and J. Van-Snick. 1990. Mouse plasmacytoma growth in vivo: enhancement by interleukin-6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J. Exp. Med. 172:997-1000.
30. Hatch, G. E., R. Slade, A. G. Stead, and J. A. Graham. 1986. Species comparison of acute inhalation toxicity of ozone and phosgene. J. Toxicol. Environ. Health 19:43-53.
31. Bradford, M. M. A. 1976. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254.
32. Kutnink, M. A., J. H. Skala, H. E. Sauberlich, and S. T. Omaye. 1985. Simultaneous determination of ascorbic acid, isoascorbic acid (erythorbic acid) and uric acid in human plasma by high-performance liquid chromatography with amperometric detection. J. Liq. Chromatogr. 8:31-46.
33. Anderson, M. E. 1985. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113:548-555.
34. Jaskot, R. H., E. G. Charlet, E. C. Grose, M. A. Grady, and J. A. H. Roycroft. 1983. An automated analysis of glutathione peroxidase, S-transferase, and reductase activity in animal tissue. J. Anal. Toxicol. 7:86-88.
35. Mustafa, M. G., A. D. Hacker, J. J. Ospital, M. Z. Husain, and S. D. Lee. 1977. Biochemical effects of environmental oxidant pollutants in animal lungs. In Biochemical Effects of Environmental Pollutants. S. D. Lee, editor. Ann Arbor Science Publishing. Ann Arbor, MI. 75-96.
36. Minami, M., and H. Yoshikawa. 1979. A simplified assay method of superoxide dismutase activity for clinical use. Clin. Chim. Acta 92:337-342.
37. 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Exp. Med. 165:914-919.
38. Malek, F. Y., M. J. Utell, R. J. Looney, P. E. Morrow, P. C. Levy, Y. Tsai, R. Barth, and M. W. Frampton. 1995. Does exposure to ozone induce systemic acute phase response in humans? Am. Rev. Respir. Dis. 151:A27. (Abstr.)
39. Tsan, M. F., T. A. White, S. Y. Lee, and C. Y. Lee. 1990. Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity. J. Appl. Physiol. (Lung Cell Mol. Physiol. 3) 68:1211-1219.
40. Koto, H., M. Salmon, E. B. Haddad, T. J. Huang, J. Zargorski, and K. F. Chung. 1997. Role of cytokine-induced neutrophil chemoattractant (CINC) in ozone-induced airway inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 156:234-239.
41. Afford, S. C, J. Pongracz, R. A. Stockley, J. Crocker, and D. Burnett. 1992. The induction by human interleukin-6 of apoptosis in the promonocytic cell line u937 and human neutrophils. J. Biol. Chem. 267:21612-21616.
42. Geiger, T., T. Andus, J. Klapporth, T. Hirano, T. Kishimoto, and P. C. Heinrich. 1988. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18:717-721.
43. Marinkovic, S., G. P. Jahreis, G. G. Wong, and H. Baumann. 1989. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J. Immunol. 142:808-812.
44. Kushner, I. 1982. The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389:39-48.
45. Kew, R. R., T. M. Hyers, and R. O. Webster. 1990. Human C-reactive protein inhibits neutrophils chemotaxis in vitro: possible implications for the adult respiratory distress syndrome. J. Lab. Clin. Med. 115:339-345.
46. Heuertz, R. M., C. A. Piquette, and R. O. Webster. 1993. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am. J. Pathol. 142: 319-328.
47. Heuertz, R. M., D. Xia, D. Samols, and R. O. Webster. 1994. Inhibition of C5a des arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am. J. Physiol. (Lung Cell Mol. Physiol. 10) 266:L649-L654.
48. Laskin, D. L., K. J. Pendino, C. J. Punjabi, M. Rodriguez del Valle, and J. D. Laskin. 1994. Pulmonary and hepatic effects of inhaled ozone in rats. Environ. Health Perspect. 102:61-64.
49. Yang, F., W. E. Friedrichs, A. L. Navarijo-Ashbaugh, L. A. Degraffenried, B. H. Bowman, and J. J. Coalson. 1995. Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung. Lab. Invest. 73:433-440.
50. Rahman, I., L. B. Clerch, and D. Massaro. 1991. Rat lung antioxidant enzyme induction by ozone. Am. J. Physiol. 260:L412-L418.
51. 1) in rats by actinomycin D and colchicine. Environ. Res. 29:62-69.
52. Oldenburg, H. S. A., M. A. Rogy, D. D. Lazarus, K. J. Van Zee, B. P. Keeler, R. A. Chizzonite, S. F. Lowrys, and L. L. Moldawer. 1993. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur. J. Immunol. 23:1889-1893.
53. Strassman, G., M. Fong, S. Windsor, and R. Neta. 1993. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production in vivo. Cytokine 5:285-292.
54. May, L. T., M. I. Ndubuisi, K. Patel, and D. Garcia. 1995. Interleukin-6 chaperones in blood. Ann. NY Acad. Sci. 762:120-128.
55. Ulich, T. R., S. Yin, K. Guo, S. E. Yi, D. Remick, and J. D. Castillo. 1991. Intratracheal injection of endoxin and cytokines: II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol. 138:1097-1101.
56. Maruo, N., I. Morita, M. Shirao, and S. Murota. 1992. IL-6 increases endothelial permeability in vitro. Endocrinology 131:710-714.